Literature DB >> 11171022

Vaginal mucosal immunization for recurrent urinary tract infection: extended phase II clinical trial.

D T Uehling1, W J Hopkins, L M Beierle, J V Kryger, D M Heisey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11171022     DOI： 10.1086/318839

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  10 in total

1.  Vaccine Development for the Prevention of Urinary Tract Infections.

Authors:  Walter J. Hopkins; David T. Uehling
Journal:  Curr Infect Dis Rep       Date:  2002-12       Impact factor: 3.725

Review 2.  Pathogenesis of Proteus mirabilis Infection.

Authors:  Chelsie E Armbruster; Harry L T Mobley; Melanie M Pearson
Journal:  EcoSal Plus       Date:  2018-02

3.  UTI patients have pre-existing antigen-specific antibody titers against UTI vaccine antigens.

Authors:  Christina A Sarkissian; Christopher J Alteri; Harry L T Mobley
Journal:  Vaccine       Date:  2019-07-15       Impact factor: 3.641

Review 4.  Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine.

Authors:  Ariel R Brumbaugh; Harry L T Mobley
Journal:  Expert Rev Vaccines       Date:  2012-06       Impact factor: 5.217

Review 5.  Urinary tract infections in the frail elderly: issues for diagnosis, treatment and prevention.

Authors:  Chesley L Richards
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

Review 6.  Recurrent urinary tract infection in women: emerging concepts regarding etiology and treatment considerations.

Authors:  E Ann Gormley
Journal:  Curr Urol Rep       Date:  2003-10       Impact factor: 3.092

Review 7.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02

Review 8.  Waging war against uropathogenic Escherichia coli: winning back the urinary tract.

Authors:  Kelsey E Sivick; Harry L T Mobley
Journal:  Infect Immun       Date:  2009-11-16       Impact factor: 3.441

Review 9.  Management of bacterial urinary tract infections in adult patients with diabetes mellitus.

Authors:  Ruby Meiland; Suzanne E Geerlings; Andy I M Hoepelman
Journal:  Drugs       Date:  2002       Impact factor: 9.546

10.  Intravaginal immunization using the recombinant HIV-1 clade-C trimeric envelope glycoprotein CN54gp140 formulated within lyophilized solid dosage forms.

Authors:  Louise Donnelly; Rhonda M Curran; John S Tregoning; Paul F McKay; Tom Cole; Ryan J Morrow; Vicky L Kett; Gavin P Andrews; A David Woolfson; R Karl Malcolm; Robin J Shattock
Journal:  Vaccine       Date:  2011-04-21       Impact factor: 3.641
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.